Narrative reviewRecommendations for Successful Transition of Adolescents With Inflammatory Bowel Diseases to Adult Care
Section snippets
Results
A total of 38 studies with 7631 subjects met the eligibility criteria (Table 2). Subjects included 6314 patients (1914 pretransition, 3747 post-transition, 27 undergoing transition, and 626 adult-onset IBD), 334 parents of patients with IBD, 282 pediatric gastroenterologists, 461 adult gastroenterologists, 88 gastroenterologists not specified, 138 nurses, 2 psychologists, 1 nurse practitioner, 1 social worker, 1 administrator, and 9 unspecified. Seven of 38 studies (18.4%) had comparison groups
Discussion
The existing IBD transition literature has gone to great lengths to provide meaningful perspectives from patients, parents, and providers regarding concerns about the transition process and transfer of care. Despite continued growth in that literature, our study showed key research gaps. Transition readiness is the most frequently addressed of the Six Core Elements of Transition; however, it has been assessed heterogeneously with multiple different instruments. Moreover, none of the existing
References (70)
- et al.
Resource utilization during pediatric to adult transfer of care in IBD
J Crohns Colitis
(2013) - et al.
Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease
Gastroenterology
(2008) - et al.
Transition of gastroenterological patients from paediatric to adult care: a position statement by the Italian Societies of Gastroenterology
Dig Liv Dis
(2015) - et al.
Multi-site comparison of patient, parent, and pediatric provider perspectives on transition to adult care in IBD
J Pediatr Nurs
(2018) - et al.
Self-efficacy in adolescents with inflammatory bowel disease: a pilot study of the “IBD-yourself”, a disease-specific questionnaire
J Crohns Colitis
(2013) - et al.
The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: differing perceptions from a survey of adult and paediatric gastroenterologists
J Crohns Colitis
(2012) - et al.
Clinicians poorly assess health literacy-related readiness for transition to adult care in adolescents with inflammatory bowel disease
Clin Gastroenterol Hepatol
(2012) - et al.
Evaluation of outcomes in adolescent inflammatory bowel disease patients following transfer from pediatric to adult health care services: case for transition
J Adolesc Health
(2015) - et al.
Children with inflammatory bowel disease: assessment of the transition from pediatric to the adult care unit
Arch Pediatr
(2017) - et al.
A systematic review of the psychometric properties of transition readiness assessment tools in adolescents with chronic disease
BMC Pediatr
(2014)
Surgeon General’s conference. Growing up and getting medical care: youth with special health care needs
TRansitions Clinical Report Authoring Group, et al. Supporting the health care transition from adolescence to adulthood in the medical home
Pediatrics
Transition planning among US youth with and without special health care needs
Pediatrics
Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population
Dig Dis Sci
Oral medication adherence and disease severity in pediatric inflammatory bowel disease
Eur J Gastroenterol Hepatol
Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
J Pediatr Gastroenterol Nutr
Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist
Inflamm Bowel Dis
UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care
Gut
European Crohn's and Colitis Organisation topical review on transitional care in inflammatory bowel disease
J Crohns Colitis
Current transition practices in pediatric IBD: findings from a national survey of pediatric providers
Inflamm Bowel Dis
Challenges in transitional care in inflammatory bowel disease: a review of the current literature in transition readiness and outcomes
Inflamm Bowel Dis
Transition readiness skills acquisition in adolescents and young adults with inflammatory bowel disease: findings from integrating assessment into clinical practice
Inflamm Bowel Dis
Transition of inflammatory bowel disease care: assessment of transition readiness factors and disease outcomes in a young adult population
Inflamm Bowel Dis
Assessing the transition intervention needs of young adults with inflammatory bowel diseases
J Pediatr Gastroenterol Nutr
Self-efficacy and resilience are useful predictors of transition readiness scores in adolescents with inflammatory bowel diseases
Inflamm Bowel Dis
What teens do not know can hurt them: an assessment of disease knowledge in adolescents and young adults with IBD
Inflamm Bowel Dis
Moving on: transition readiness in adolescents and young adults with IBD
Inflamm Bowel Dis
Adolescent transition clinic in inflammatory bowel disease: quantitative assessment of self-efficacy skills
Eur J Gastroenterol Hepatol
Self-efficacy did not predict the outcome of the transition to adult care in adolescents with inflammatory bowel disease
Acta Paediatr
Chronological age when healthcare transition skills are mastered in adolescents/young adults with inflammatory bowel disease
World J Gastroenterol
Are expectations too high for transitioning adolescents with inflammatory bowel disease? Examining adult medication knowledge and self-management skills
J Pediatr Gastroenterol Nutr
When independent healthcare behaviors develop in adolescents with inflammatory bowel disease
Inflamm Bowel Dis
Transition readiness in pediatric patients with inflammatory bowel disease: patient survey of self-management skills
J Pediatr Gastroenterol Nutr
Patient and caregiver perspectives on transition and transfer
Clin Pediatr
Concerns, barriers, and recommendations to improve transition from pediatric to adult IBD care: perspectives of patients, parents, and health professionals
Inflamm Bowel Dis
Cited by (16)
Implementation of programmes for the transition of adolescents to adult care
2023, Anales de Pediatria‘Adulting’ with IBD: Efficacy of a novel virtual transition workshop for pediatric inflammatory bowel disease
2021, Journal of Pediatric NursingCitation Excerpt :Participants will be asked to complete the measures again at one year post-transition workshop. The following assessment measures were chosen based on literature demonstrating that both tangible transition skills building and disease self-efficacy are associated with transition readiness and better health outcomes in the adult environment (Carlsen et al., 2017; Graff et al., 2016; Keefer et al., 2011; Shapiro et al., 2020). The Transition Readiness Assessment (TRAQ) was chosen as the primary measure to assess participant's independence in performing tangible actions associated with transition readiness including managing medications, making appointments, and communicating with health care providers (Wood et al., 2014).
Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease care models?
2020, Digestive and Liver DiseaseCitation Excerpt :The “treat to target” paradigm [24] can be adapted to transition care. It involves a baseline risk- assessment of paediatric patients, by identifying potential barriers, selecting an initial transition programme wherein management is adjusted according to regular monitoring with non-invasive means to reach the agreed goals [25,26] (Fig. 1). Monitoring will continue to include BMI, growth and development in addition to such other objective measures as faecal calprotectin (FC), C-reactive protein, colonoscopy and cross-sectional imaging.
Pediatric-to-Adult Transfer of Care in Patients with Pancreas Disease: Recommendations for Care and Research Opportunities
2023, American Journal of Gastroenterology
Conflicts of interest This author discloses the following: Jason Hou has served as a speaker for AbbVie, Janssen, and Pfizer, has consulted for AbbVie, has served on advisory boards for Pfizer, AbbVie, and Janssen, and has received research funding from AbbVie, Janssen, Pfizer, Celgene, Genentech, Redhill Biopharma, and Eli-Lilly. The remaining authors disclose no conflicts.
Funding Jordan M. Shapiro is supported by a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Institutional National Service Award (T32) from the National Institutes of Health under Award Number 5T32DK083266-09.